SR-878

DRUG2 trials

Sponsors

SciRhom GmbH

Conditions

Healthy VolunteersRheumatoid Arthritis

Phase 1

Study Investigating the Safety, Tolerability and Blood Concentration of the Substance SR-878

TerminatedNCT06607484

SciRhom GmbHHealthy Volunteers

Start: 2024-10-08End: 2025-02-27Updated: 2025-06-03

A Study to Assess the Safety and Tolerability of SR-878 in Patients With Rheumatoid Arthritis

RecruitingNCT07433335

SciRhom GmbHRheumatoid Arthritis

Start: 2026-04-07End: 2028-02-29Target: 27Updated: 2026-05-11